Dominant-negative proteins in herpesviruses - from assigning gene function to intracellular immunization

Viruses

Volumn 1, Issue 3, 2009, Pages 420-440

  Mühlbach, Hermine ^a   Mohr, Christian A ^a   Ruzsics, Zsolt ^a   Koszinowski, Ulrich H ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Conditional gene expression; Conserved gene blocks; Deletion; Dominant negative; Essential genes; Herpesvirus; Intracellular immunization; Random mutagenesis

Indexed keywords

EID: 84858615003     PISSN: 19994915     EISSN: None     Source Type: Journal    
DOI: 10.3390/v1030420     Document Type: Review

References (112)

1. Roizman, B.; Baines, J. The Diversity and Unity of Herpes-Viridae. Comp. Immunol. Microb. 1991, 2, 63-79.
2. Fu, M.; Deng, R.; Wang, J.; Wang, X. Whole-Genome Phylogenetic Analysis of Herpesviruses. Acta Virol. 2008, 1, 31-40.
3. Davison, A.J. Evolution of the herpesviruses. Vet. Microbiol. 2002, 1-2, 69-88.
4. McGeoch, D.J.; Rixon, F. J.; Davison, A.J. Topics in herpesvirus genomics and evolution. Virus Res. 2006, 1, 90-104.
5. Alcami, A.; Koszinowski, U.H. Viral mechanisms of immune evasion. Immunol. Today 2000, 9, 447-455.
6. Mori, I.; Nishiyama, Y. Herpes simplex virus and varicella-zoster virus: why do these human alphaherpesviruses behave so differently from one another? Rev. Med. Virol. 2005, 6, 393-406.
7. Andoniou, C.E.; Degli-Esposti, M.A. Insights into the mechanisms of CMV-mediated interference with cellular apoptosis. Immunol. Cell. Biol. 2006, 1, 99-106.
8. Matis, J.; Kudelova, M. Early shutoff of host protein synthesis in cells infected with herpes simplex viruses. Acta. Virol. 2001, 5-6, 269-277.
9. Dunn, W.; Chou, C.; Li, H.; Hai, R.; Patterson, D.; Stolc, V.; Zhu, H.; Liu, F.Y. Functional profiling of a human cytomegalovirus genome. Proc. Natl. Acad. Sci. U S A 2003, 24, 14223-14228.
10. Herskowitz, I. Functional Inactivation of Genes by Dominant Negative Mutations. Nature 1987, 6136, 219-222.
11. Wang, N.; Baldi, P.F.; Gaut, B.S. Phylogenetic analysis, genome evolution and the rate of gene gain in the Herpesviridae. Mol. Phylogenet. Evol. 2007, 3, 1066-1075.
12. Montague, M.G.; Hutchison, C.A. Gene content phylogeny of herpesviruses. Proc. Natl. Acad. Sci. U S A 2000, 10, 5334-5339.
13. Pellett, P.E.; Roizman, B. The Family Herpesviridae: A Brief Introduction 2007, 66, 2479-2499.
14. Salsman, J.; Zimmerman, N.; Chen, T.; Domagala, M.; Frappier, L. Genome-wide screen of three herpesviruses for protein subcellular localization and alteration of PML nuclear bodies. Plos Pathogens 2008, 7.
15. Sweet, C.; Ball, K.; Morley, P.J.; Guilfoyle, K.; Kirby, M. Mutations in the temperature-sensitive murine cytomegalovirus (MCMV) mutants tsm5 and tsm30: A study of genes involved in immune evasion, DNA packaging and processing, and DNA replication. J. Med. Virol. 2007, 3, 285-299.
16. Benyesh-Melnick, M.; Schaffer, P.A.; Courtney, R.J.; Esparza, J.; Kimura, S. Viral gene functions expressed and detected by temperature-sensitive mutants of herpes simplex virus. Cold Spring Harb. Symp. Quant. Biol. 1975, 731-746.
17. Akel, H.M.O.; Sweet, C. Isolation and Preliminary Characterization of 25 Temperature-Sensitive Mutants of Mouse Cytomegalovirus. FEMS Microbiol. Lett. 1993, 3, 253-260.
18. Hahn, G.; Revello, M.G.; Patrone, M.; Percivalle, E.; Campanini, G.; Sarasini, A.; Wagner, M.; Gallina, A.; Milanesi, G.; Koszinowski, U.; Baldanti, F.; Gerna, G. Human cytomegalovirus UL131-128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes. J. Virol. 2004, 18, 10023-10033.
19. Mocarski, E.S.; Post, L.E.; Roizman, B. Molecular Engineering of the Herpes-Simplex Virus Genome-Insertion of A Second L-S Junction Into the Genome Causes Additional Genome Inversions. Cell 1980, 1, 243-255.
20. Messerle, M.; Crnkovic, I.; Hammerschmidt, W.; Ziegler, H.; Koszinowski, U.H. Cloning and mutagenesis of a herpesvirus genome as an infectious bacterial artificial chromosome. Proc. Natl. Acad. Sci. U S A 1997, 26, 14759-14763.
21. Brune, W.; Messerle, M.; Koszinowski, U.H. Forward with BACs-new tools for herpesvirus genomics. Trends Genet. 2000, 6, 254-259.
22. Adler, H.; Messerle, M.; Koszinowski, U.H. Cloning of herpesviral genomes as bacterial artificial chromosomes. Rev. Med. Virol. 2003, 2, 111-121.
23. Brune, W.; Menard, C.; Hobom, U.; Odenbreit, S.; Messerle, M.; Koszinowski, U.H. Rapid identification of essential and nonessential herpesvirus genes by direct transposon mutagenesis. Nature Biotech. 1999, 4, 360-364.
24. Yu, D.; Silva, M.C.; Shenk, T. Functional map of human cytomegalovirus AD169 defined by global mutational analysis. Proc. Natl. Acad. Sci. U S A 2003, 21, 12396-12401.
25. Hobom, U.; Brune, W.; Messerle, M.; Hahn, G.; Koszinowski, U.H. Fast screening procedures for random transposon libraries of cloned herpesvirus genomes: Mutational analysis of human cytomegalovirus envelope glycoprotein genes. J. Virol. 2000, 17, 7720-7729.
26. Smith, G.A.; Enquist, L.W. Construction and transposon mutagenesis in Escherichica coli of a full-length infectious clone of pseudorabies virus, an alphaherpesvirus. J. Virol. 1999, 8, 6405-6414.
27. Menard, C.; Wagner, M.; Ruzsics, Z.; Holak, K.; Brune, W.; Campbell, A.E.; Koszinowski, U.H. Role of murine cytomegalovirus US22 gene family members in replication in macrophages. J. Virol. 2003, 10, 5557-5570.
28. Brune, W.; Menard, C.; Heesemann, J.; Koszinowski, U.H. A ribonucleotide reductase homolog of cytomegalovirus and endothelial cell tropism. Science 2001, 5502, 303-305.
29. Ruzsics, Z.; Wagner, M.; Osterlehner, A.; Cook, J.; Koszinowski, U.; Burgert, H.G. Transposonassisted cloning and traceless mutagenesis of adenoviruses: Development of a novel vector based on species D. J. Virol. 2006, 16, 8100-8113.
30. Tischer, B.K.; von Einem, J.; Kaufer, B.; Osterrieder, N. Two-step Red-mediated recombination for versatile high-efficiency markerless DNA manipulation in Escherichia coli. Biotechniques 2006, 2, 191-197.
31. Bubic, I.; Wagner, M.; Krmpotic, A.; Saulig, T.; Kim, S.; Yokoyama, W.M.; Jonjic, S.; Koszinowski, U.H. Gain of virulence caused by loss of a gene in murine cytomegalovirus. J. Virol. 2004, 14, 7536-7544.
32. Champier, G.; Hantz, S.; Couvreux, A.; Stuppfler, S.; Mazeron, M.C.; Bouaziz, S.; Denis, F.; Alain, S. New functional domains of human cytomegalovirus pUL89 predicted by sequence analysis and three-dimensional modelling of the catalytic site DEXDc. Antiviral Ther. 2007, 2, 217-232.
33. Holzerlandt, R.; Orengo, C.; Kellam, P.; Alba, M.M. Identification of new herpesvirus gene homologs in the human genome. Genome Res. 2002, 11, 1739-1748.
34. Bottcher, S.; Klupp, B.G.; Granzow, H.; Fuchs, W.; Michael, K.; Mettenleiter, T.C. Identification of a 709-amino-acid internal nonessential region within the essential conserved tegument protein (p)UL36 of pseudorabies virus. J. Virol. 2006, 19, 9910-9915.
35. Veitia, R.A. Exploring the molecular etiology of dominant-negative mutations. Plant Cell 2007, 12, 3843-3851.
36. Veitia, R.A. Dominant negative factors in health and disease. J. Pathol. 2009, 218, 409-418.
37. Fujita, H.; Yamanaka, M.; Imamura, K.; Tanaka, Y.; Nara, A.; Yoshimori, T.; Yokota, S.; Himeno, M. A dominant negative form of the AAA ATPase SKD1/VPS4 impairs membrane trafficking out of endosomal/lysosomal compartments: class E vps phenotype in mammalian cells. J. Cell. Sci. 2003, 2, 401-414.
38. Hendershot, L.M.; Wei, J.Y.; Gaut, J.R.; Melnick, J.; Aviel, S.; Argon, Y. Inhibition of Immunoglobulin Folding and Secretion by Dominant-Negative Bip Atpase Mutants. Mol. Biol. Cell. 1995, 375-375.
39. Tabancay, A.P.; Gau, C.L.; Machado, I.M.P.; Uhlmann, E.J.; Gutmann, D.H.; Guo, L.; Tamanoi, F. Identification of dominant negative mutants of Rheb GTPase and their use to implicate the involvement of human Rheb in the activation of p70S6K. J. Biol. Chem. 2003, 41, 39921-39930.
40. Bishop, A.L.; Hall, A. Rho GTPases and their effector proteins. Biochem. J. 2000, 241-255.
41. Rodriguez-Frade, J.M.; Vila-Coro, A.J.; de Ana, A.M.; Albar, J.P.; Martinez, A.; Mellado, M. The chemokine monocyte chemoattractant protein-1 induces functional responses through dimerization of its receptor CCR2. Proc. Natl. Acad. Sci. U S A 1999, 7, 3628-3633.
42. Caldenhoven, E.; vanDijk, T.B.; Solari, R.; Armstrong, J.; Raaijmakers, J.A.M.; Lammers, J.W.J.; Koenderman, L.; deGroot, R.P. STAT3 beta, a splice variant of transcription factor STAT3, is a dominant negative regulator of transcription. J. Biol. Chem. 1996, 22, 13221-13227.
43. Barren, B.; Artemyev, N.O. Mechanisms of dominant negative G-protein alpha subunits. J. Neurosci. Res. 2007, 16, 3505-3514.
44. Willis, A.; Jung, E.J.; Wakefield, T.; Chen, X.B. Mutant p53 exerts a dominant negative effect by preventing wild-type p53 from binding to the promoter of its target genes. Oncogene 2004, 13, 2330-2338.
45. Fire, A.; Xu, S.Q.; Montgomery, M.K.; Kostas, S.A.; Driver, S.E.; Mello, C.C. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998, 6669, 806-811.
46. Hinshaw, J.E. Dynamin and its role in membrane fission. Annu. Rev. Cell Dev. Biol. 2000, 16, 483-519.
47. Damke, H.; Baba, T.; Warnock, D.E.; Schmid, S.L. Induction of Mutant Dynamin Specifically Blocks Endocytic Coated Vesicle Formation. J. Cell. Biol. 1994, 4, 915-934.
48. Damke, H.; Binns, D.D.; Ueda, H.; Schmid, S.L.; Baba, T. Dynamin GTPase domain mutants block endocytic vesicle formation at morphologically distinct stages. Mol. Biol. Cell. 2001, 9, 2578-2589.
49. Lee, A.; Frank, D.W.; Marks, M.S.; Lemmon, M.A. Dominant-negative inhibition of receptormediated endocytosis by a dynamin-1 mutant with a defective pleckstrin homology domain. Curr. Biol. 1999, 5, 261-264.
50. Achiriloaie, M.; Barylko, B.; Albanesi, J.P. Essential role of the dynamin pleckstrin homology domain in receptor-mediated endocytosis. Mol. Cell. Biol. 1999, 2, 1410-1415.
51. Szaszak, M.; Gaborik, Z.; Turu, G.; McPherson, P.S.; Clark, A.J.L.; Catt, K.J.; Hunyady, L. Role of the proline-rich domain of dynamin-2 and its interactions with Src homology 3 domains during endocytosis of the AT(1) angiotensin receptor. J. Biol. Chem. 2002, 24, 21650-21656.
52. Marks, B.; Stowell, M.H.B.; Vallis, Y.; Mills, I.G.; Gibson, A.; Hopkins, C.R.; McMahon, H.T. GTPase activity of dynamin and resulting conformation change are essential for endocytosis. Nature 2001, 6825, 231-235.
53. Daecke, J.; Fackler, O.T.; Dittmar, M.T.; Krausslich, H.G. Involvement of clathrin-mediated endocytosis in human immunodeficiency virus type 1 entry. J. Virol. 2005, 3, 1581-1594
54. Spoden, G.; Freitag, K.; Husmann, M.; Boller, K.; Sapp, M.; Lambert, C.; Florin, L. Clathrin-and caveolin-independent entry of human papillomavirus type 16--involvement of tetraspaninenriched microdomains (TEMs). PLoS One 2008, 10, e3313.
55. Heldwein, E.E.; Krummenacher, C. Entry of herpesviruses into mammalian cells. Cell. Mol. Life Sci. 2008, 11, 1653-1668.
56. Cheshenko, N.; Liu, W.; Satlin, L.M.; Herold, B.C. Focal adhesion kinase plays a pivotal role in herpes simplex virus entry. J. Biol. Chem. 2005, 35, 31116-31125.
57. Veettil, M.V.; Sharma-Walia, N.; Sadagopan, S.; Raghu, H.; Sivakumar, R.; Naranatt, P.P.; Chandran, B. RhoA-GTPase facilitates entry of Kaposi's sarcoma-associated herpesvirus into adherent target cells in a Src-dependent manner. J. Virol. 2006, 23, 11432-11446.
58. Sharma-Walia, N.; Naranatt, P.P.; Krishnan, H.H.; Zeng, L.; Chandran, B. Kaposi's sarcomaassociated herpesvirus/human herpesvirus 8 envelope glycoprotein gB induces the integrindependent focal adhesion kinase-Src-phosphatidylinositol 3-kinase-Rho GTPase signal pathways and cytoskeletal rearrangements. J. Virol. 2004, 8, 4207-4223.
59. Krishnan, H.H.; Sharma-Walia, N.; Streblow, D.N.; Naranatt, P.P.; Chandran, B. Focal adhesion kinase is critical for entry of Kaposi's sarcoma-associated herpesvirus into target cells. J. Virol. 2006, 3, 1167-1180.
60. Advani, S.J.; Weichselbaum, R.R.; Roizman, B. The role of cdc2 in the expression of herpes simplex virus genes. Proc. Natl. Acad. Sci. U S A 2000, 20, 10996-11001.
61. Gu, H.D.; Roizman, B. The degradation of promyelocytic leukemia and Sp100 proteins by herpes simplex virus 1 is mediated by the ubiquitin-conjugating enzyme UbcH5a. Proc. Natl. Acad. Sci. U S A 2003, 15, 8963-8968.
62. Cicin-Sain, L.; Ruzsics, Z.; Podlech, J.; Bubic, I.; Menard, C.; Jonjic, S.; Reddehase, M.J.; Koszinowski, U.H. Dominant-negative FADD rescues the in vivo fitness of a cytomegalovirus lacking an antiapoptotic viral gene. J. Virol. 2008, 5, 2056-2064.
63. Walters, M.S.; Hall, K.T.; Whitehouse, A. The herpesvirus saimiri open reading frame (ORF) 50 (Rta) protein contains an AT hook required for binding to the ORF 50 response element in delayed-early promoters. J. Virol. 2004, 9, 4936-4942.
64. Rossetto, C.; Yamboliev, I.; Pari, G.S. Kaposi's Sarcoma-Associated Herpesvirus/Human Herpesvirus 8 K-bZIP modulates LANA mediated suppression of lytic origin-dependent DNA synthesis. J. Virol. 2009, 83, 8492-8501.
65. McNamee, E.E.; Taylor, T.J.; Knipe, D.M. A dominant-negative herpesvirus protein inhibits intranuclear targeting of viral proteins: Effects on DNA replication and late gene expression. J. Virol. 2000, 21, 10122-10131.
66. Watanabe, S.; Ono, E.; Shimizu, Y.; Kida, H. Mapping of transregulatory domains of pseudorabies virus early protein 0 and identification of its dominant-negative mutant. Arch. Virol. 1996, 6, 1001-1009.
67. Kim, S.K.; Ahn, B.C.; Albrecht, R.A.; O'Callaghan, D.J. The unique IR2 protein of equine herpesvirus 1 negatively regulates viral gene expression. J. Virol. 2006, 10, 5041-5049.
68. Kirchmaier, A.L.; Sugden, B. Dominant-negative inhibitors of EBNA-1 of Epstein-Barr virus. J. Virol. 1997, 3, 1766-1775.
69. Marintcheva, B.; Weller, S.K. Existence of transdominant and potentiating mutants of UL9, the herpes simplex virus type 1 origin-binding protein, suggests that levels of UL9 protein may be regulated during infection. J. Virol. 2003, 17, 9639-9651.
70. Olivo, P.D.; Nelson, N.J.; Challberg, M.D. Herpes-Simplex Virus-Dna Replication-the Ul9 Gene Encodes An Origin-Binding Protein. Proc. Natl. Acad. Sci. U S A 1988, 15, 5414-5418
71. Yao, F.; Eriksson, E. A novel anti-herpes simplex virus type 1-specific herpes simplex virus type 1 recombinant. Hum. Gene Ther. 1999, 11, 1811-1818.
72. Yao, F.; Eriksson, E. Inhibition of herpes simplex virus type 2 (HSV-2) viral replication by the dominant negative mutant polypeptide of HSV-1 origin binding protein. Antiviral Res. 2002, 2, 127-133.
73. Augustinova, H.; Hoeller, D.; Yao, F. The dominant-negative herpes simplex virus type 1 (HSV-1) recombinant CJ83193 can serve as an effective vaccine against wild-type HSV-1 infection in mice. J. Virol. 2004, 11, 5756-5765.
74. Brans, R.; Eriksson, E.; Yao, F. Immunization with a Dominant-Negative Recombinant HSV Type 1 Protects against HSV-1 Skin Disease in Guinea Pigs. J. Invest. Dermatol. 2008, 12, 2825-2832
75. Prockop, D.J.; Kivirikko, K.I. Collagens-Molecular-Biology, Diseases, and Potentials for Therapy. Annu. Rev. Biochem. 1995, 403-434.
76. Friedman, A.D.; Triezenberg, S.J.; Mcknight, S.L. Expression of A Truncated Viral Trans-Activator Selectively Impedes Lytic Infection by Its Cognate Virus. Nature 1988, 6189, 452-454.
77. Weber, P.C.; Wigdahl, B. Identification of Dominant-Negative Mutants of the Herpes-Simplex Virus Type-1 Immediate-Early Protein-Icp0. J. Virol. 1992, 4, 2261-2267.
78. Borst, E.M.; Mathys, S.; Wagner, M.; Muranyi, W.; Messerle, M. Genetic evidence of an essential role for cytomegalovirus small capsid protein in viral growth. J. Virol. 2001, 3, 1450-1458.
79. Holzmayer, T.A.; Pestov, D.G.; Roninson, I.B. Isolation of Dominant Negative Mutants and Inhibitory Antisense Rna Sequences by Expression Selection of Random Dna Fragments. Nucleic Acids Res. 1992, 4, 711-717.
80. Steel, G.J.; Harley, C.; Boyd, A.; Morgan, A. A screen for dominant negative mutants of SEC18 reveals a role for the AAA protein consensus sequence in ATP hydrolysis. Mol. Biol. Cell 2000, 4, 1345-1356.
81. Crowder, S.; Kirkegaard, K. Trans-dominant inhibition of RNA viral replication can slow growth of drug-resistant viruses. Nature Genet. 2005, 7, 701-709.
82. Cunningham, B.C.; Wells, J.A. High-Resolution Epitope Mapping of Hgh-Receptor Interactions by Alanine-Scanning Mutagenesis. Science 1989, 4908, 1081-1085.
83. Thompson, D.K.; Garbers, D.L. Dominant-Negative Mutations of the Guanylyl Cyclase-A Receptor-Extracellular Domain Deletion and Catalytic Domain Point Mutations. J. Biol. Chem. 1995, 1, 425-430
84. Steel, G.J.; Harley, C.; Boyd, A.; Morgan, A. A screen for dominant negative mutants of SEC18 reveals a role for the AAA protein consensus sequence in ATP hydrolysis. Mol. Bio. Cell 2000, 4, 1345-1356.
85. Hayes, F. Transposon-based strategies for microbial functional genomics and proteomics. Annu. Rev. Genet. 2003, 3-29.
86. Ruzsics, Z.; Koszinowski, U.H. Mutagenesis of the cytomegalovirus genome. In Human Cytomegalovirus; Shenk, T., Stinki, M.F., Eds.; Current Topics in Microbiology and Immunology; Springer: Berlin/Heidelberg, Germany, 2008; 41-61.
87. Bubeck, A.; Wagner, M.; Ruzsics, Z.; Lotzerich, M.; Iglesias, M.; Singh, I.R.; Koszinowski, U.H. Comprehensive mutational analysis of a herpesvirus gene in the viral genome context reveals a region essential for virus replication. J. Virol. 2004, 15, 8026-8035.
88. Lotzerich, M.; Ruzsics, Z.; Koszinowski, U.H. Functional domains of murine cytomegalovirus nuclear egress protein M53/p38. J. Virol. 2006, 1, 73-84.
89. Rupp, B.; Ruzsics, Z.; Sacher, T.; Koszinowski, U.H. Conditional cytomegalovirus replication in vitro and in vivo. J. Virol. 2005, 1, 486-494.
90. Rupp, B.; Ruzsics, Z.; Buser, C.; Adler, B.; Walther, P.; Koszinowski, U.H. Random screening for dominant-negative mutants of the cytomegalovirus nuclear egress protein M50. J. Virol. 2007, 11, 5508-5517.
91. Granato, M.; Feederle, R.; Farina, A.; Gonnella, R.; Santarelli, R.; Hub, B.; Faggioni, A.; Delecluse, H.J. Deletion of Epstein-Barr virus BFLF2 leads to impaired viral DNA packaging and primary egress as well as to the production of defective viral particles. J. Virol. 2008, 8, 4042-4051.
92. Lapik, Y.R.; Fernandes, C.J.; Lau, L.F.; Pestov, D.G. Physical and functional interaction between pes1 and bop1 in mammalian ribosome biogenesis. Mol. Cell 2004, 1, 17-29.
93. Osawa, M.; Erickson, H.P. Probing the domain structure of FtsZ by random insertional mutagenesis. Mol. Bio. Cell 2004, 292A-293A.
94. Weber, E.; Koebnik, R. Domain structure of HrpE, the Hrp pilus subunit of Xanthomonas campestris pv. vesicatoria. J. Bacteriol. 2005, 17, 6175-6186.
95. Zhang, Y.G.; Zhou, J.; Jones, C. Identification of functional domains within the bICP0 protein encoded by bovine herpesvirus 1. J. Gen. Virol. 2005, 879-886.
96. Cockrell, S.K.; Sanchez, M.E.; Erazo, A.; Homa, F.L. Role of the UL25 Protein in Herpes Simplex Virus DNA Encapsidation. J. Virol. 2009, 1, 47-57.
97. Lin, E.; Spear, P.G. Random linker-insertion mutagenesis to identify functional domains of herpes simplex virus type 1 glycoprotein B. Proc. Natl. Acad. Sci. U S A 2007, 32, 13140-13145.
98. Griffiths, D.J. Endogenous retroviruses in the human genome sequence. Genome Biol. 2001, 2, reviews1017.
99. Best, S.; Le Tissier, P.; Towers, G.; Stoye, J.P. Positional cloning of the mouse retrovirus restriction gene Fv1. Nature 1996, 6594, 826-829.
100. Arnaud, F.; Varela, M.; Spencer, T.E.; Palmarini, M. Coevolution of endogenous betaretroviruses of sheep and their host. Cell Mol. Life Sci. 2008, 21, 3422-3432.
101. Palmarini, M.; Mura, M.; Spencer, T.E. Endogenous betaretroviruses of sheep: teaching new lessons in retroviral interference and adaptation. J. Gen. Virol. 2004, 1-13.
102. Baltimore, D. Gene-Therapy-Intracellular Immunization. Nature 1988, 6189, 395-396.
103. Trono, D.; Feinberg, M.B.; Baltimore, D. Hiv-1 Gag Mutants Can Dominantly Interfere with the Replication of the Wild-Type Virus. Cell 1989, 1, 113-120.
104. Bahner, I.; Sumiyoshi, T.; Kagoda, M.; Swartout, R.; Peterson, D.; Pepper, K.; Dorey, F.; Reiser, J.; Kohn, D.B. Lentiviral vector transduction of a dominant-negative rev gene into human CD34(+) hematopoietic progenitor cells potently inhibits human immunodeficiency virus-1 replication. Mol. Ther. 2007, 1, 76-85.
105. Wunner, W.H.; Pallatroni, C.; Curtis, P.J. Selection of genetic inhibitors of rabies virus. Arch. Virol. 2004, 8, 1653-1662.
106. Jones, C.; Chowdhury, S. A review of the biology of bovine herpesvirus type 1 (BHV-1), its role as a cofactor in the bovine respiratory disease complex and development of improved vaccines. Anim. Health Res. Rev. 2007, 2, 187-205.
107. Gimeno, I.M. Marek's disease vaccines: A solution for today but a worry for tomorrow? Vaccine 2008, C31-C41.
108. Davison, A.J.; Eberle, R.; Ehlers, B.; Hayward, G.S.; McGeoch, D.J.; Minson, A.C.; Pellett, P.E.; Roizman, B.; Studdert, M.J.; Thiry, E. The order Herpesvirales. Arch. Virol. 2009, 1, 171-177.
109. Smith, C.A.; Deluca, N.A. Transdominant Inhibition of Herpes-Simplex Virus Growth in Transgenic Mice. Virology 1992, 2, 581-588.
110. Ono, E.; Sakoda, Y.; Taharaguchi, S.; Watanabe, S.; Tonomura, N.; Kida, H.; Shimizu, Y. Inhibition of Pseudorabies Virus-Replication by A Chimeric Trans-Gene Product Repressing Transcription of the Immediate-Early Gene. Virology 1995, 1, 128-140.
111. Ono, E.; Tasaki, T.; Kobayashi, T.; Taharaguchi, S.; Nikami, H.; Miyoshi, I.; Kasai, N.; Arikawa, J.; Kida, H.; Shimizu, Y. Resistance to pseudorabies virus infection in transgenic mice expressing the chimeric transgene that represses the immediate-early gene transcription. Virology 1999, 1, 72-78.
112. Tasaki, T.; Taharaguchi, S.; Kobayashi, T.; Yoshino, S.; Ono, E. Inhibition of pseudorabies virus replication by a dominant-negative mutant of early protein 0 expressed in a tetracycline-regulated system. Vet. Microbiol. 2001, 3, 195-203.